Delcath Systems Secures $35M Following FDA Approval of HEPZATO KIT
Delcath Systems, Inc., an interventional oncology company, has secured approximately $35 million through the exercise of Tranche A…
Browsing Tag
Avenue Venture Opportunities Fund
1 post